Skip to main content
Fig. 3 | BMC Pulmonary Medicine

Fig. 3

From: Effect of oral glycine on the clinical, spirometric and inflammatory status in subjects with cystic fibrosis: a pilot randomized trial

Fig. 3

Changes in selected serum and sputum cytokines in subjects with cystic fibrosis during glycine and placebo intake. All data are expressed as percentage of their respective baseline values. Symbols correspond to mean ± standard error of 9–12 subjects who received 0.5 g/kg/day glycine (filled circles) and placebo (empty circles) during 8 weeks in random order. Statistical significance was assessed through non-paired Student’s t-test. G-CSF = granulocyte colony stimulating factor; IL-6 = interleukin 6; TNF-α = tumor necrosis factor alpha

Back to article page